The testing programme will be located at the PHL Terminal E Departures building.
It will provide multiple testing options, including an antigen test and a polymerase chain reaction (PCR) test, as well as a Rapid PCR test planned in the future.
The programme has been designed for asymptomatic travellers flying out of PHL.
PHL claimed that its programme is among the most affordable in the country, with the price ranging from $70 to $130.
Standard PCR test results will be texted to passengers within 48 to 72 hours, whereas antigen test results will be sent on the same day.
For testing patrons, parking in the Terminal E Parking Garage will be complimentary for up to two hours.
PHL will be able to expand connections with destinations requiring testing prior to arrival through this programme.
PHL CEO Chellie Cameron said: “Jefferson Health and Ambulnz are ideal partners for this programme because they possess an incredible combination of world-class expertise with a focus on equity in healthcare access.
“This testing service will enable Philadelphia to safely reconnect passengers to new destinations, supporting the recovery of the entire region.”
Medical providers will administer testing in the Terminal E facility.
The facility features medically appropriate air filtration and circulation, in addition to a private office setting for each traveller.
Jefferson Health will oversee the testing via Rapid Reliable Testing, the Covid response unit of Ambulnz, a joint venture with Jefferson.
Jefferson Health CEO Stephen K Klasko said: “Jefferson has been here for our community throughout this crisis, and this is a next step in helping people conduct essential travel. Innovative partnerships work. This partnership with the Philadelphia Airport, our partner Ambulnz, and our ties to Europe give us the opportunity to develop new solutions for economic recovery.”
The programme has been designed to scale up to meet the increase in demand.